| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Animal use of antimicrobials: impact on resistance
|
Stöhr, Klaus
|
|
2000
|
|
4 |
p. 207-209
3 p.
|
artikel
|
| 2 |
Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials
|
Mross, Klaus
|
|
2000
|
|
4 |
p. 223-235
13 p.
|
artikel
|
| 3 |
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
|
Hancock, Robert E.W.
|
|
2000
|
|
4 |
p. 247-255
9 p.
|
artikel
|
| 4 |
Anticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinations
|
Broxterman, Henk J.
|
|
2005
|
|
4 |
p. 183-197
15 p.
|
artikel
|
| 5 |
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
|
Gonen, Nitzan
|
|
2012
|
|
4 |
p. 183-210
28 p.
|
artikel
|
| 6 |
Antifungal treatment in pediatric patients
|
Zaoutis, Theoklis E.
|
|
2005
|
|
4 |
p. 235-245
11 p.
|
artikel
|
| 7 |
Bacterial energetics and antimicrobial resistance
|
Proctor, Richard A.
|
|
1998
|
|
4 |
p. 227-235
9 p.
|
artikel
|
| 8 |
Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?
|
Dai, Tianhong
|
|
2012
|
|
4 |
p. 223-236
14 p.
|
artikel
|
| 9 |
Can the heat shock protein 90 inhibitor geldanamycin be designed to specifically inhibit HER-2 tyrosine kinase?
|
Neckers, Leonard M.
|
|
2000
|
|
4 |
p. 203-205
3 p.
|
artikel
|
| 10 |
Caspofungin: the first in a new class of antifungal agents
|
Kartsonis, Nicholas A
|
|
2003
|
|
4 |
p. 197-218
22 p.
|
artikel
|
| 11 |
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
|
Jung, Laura L.
|
|
2001
|
|
4 |
p. 273-288
16 p.
|
artikel
|
| 12 |
Chemotherapy of respiratory viruses: prospects and challenges
|
Wyde, Philip R.
|
|
1999
|
|
4 |
p. 244-258
15 p.
|
artikel
|
| 13 |
Clinical cancer research 2001: new agents and therapies
|
Verweij, Jacob
|
|
2001
|
|
4 |
p. 217-223
7 p.
|
artikel
|
| 14 |
Clinical cancer research 2000: new agents and therapies
|
Vries, E.G.E.de
|
|
2000
|
|
4 |
p. 197-201
5 p.
|
artikel
|
| 15 |
Differential effects of cell cycle regulatory protein p21WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy
|
Liu, Suxing
|
|
2003
|
|
4 |
p. 183-195
13 p.
|
artikel
|
| 16 |
Disrupting the p53-mdm2 interaction as a potential therapeutic modality
|
Moll, Ute M.
|
|
2000
|
|
4 |
p. 217-221
5 p.
|
artikel
|
| 17 |
Do Fanconi anemia genes control cell response to cross-linking agents by modulating cytochrome P-450 reductase activity?
|
Kruyt, Frank A.E.
|
|
2000
|
|
4 |
p. 211-215
5 p.
|
artikel
|
| 18 |
Drug resistance and the microenvironment: nature and nurture
|
Morin, Patrice J
|
|
2003
|
|
4 |
p. 169-172
4 p.
|
artikel
|
| 19 |
Drug resistance in Cryptococcus neoformans
|
Perfect, John R.
|
|
1999
|
|
4 |
p. 259-269
11 p.
|
artikel
|
| 20 |
Drug resistance in Leishmania: similarities and differences to other organisms
|
Papadopoulou, Barbara
|
|
1998
|
|
4 |
p. 266-278
13 p.
|
artikel
|
| 21 |
Drug resistance updates meetings-courses-workshops
|
|
|
2003
|
|
4 |
p. 225-230
6 p.
|
artikel
|
| 22 |
Editorial Board
|
|
|
2003
|
|
4 |
p. i-
1 p.
|
artikel
|
| 23 |
Editorial Board
|
|
|
2005
|
|
4 |
p. i-
1 p.
|
artikel
|
| 24 |
Editorial Board
|
|
|
2012
|
|
4 |
p. i-
1 p.
|
artikel
|
| 25 |
HIV protease inhibitors as new treatment options for Kaposi’s sarcoma
|
Barillari, Giovanni
|
|
2003
|
|
4 |
p. 173-181
9 p.
|
artikel
|
| 26 |
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii
|
Karah, Nabil
|
|
2012
|
|
4 |
p. 237-247
11 p.
|
artikel
|
| 27 |
Intraperitoneal chemotherapy for ovarian cancer: a question of feasibility?
|
Willemse, Pax H.B.
|
|
2003
|
|
4 |
p. 165-167
3 p.
|
artikel
|
| 28 |
β-Lactamase induction and cell wall recycling in gram-negative bacteria
|
Wiedemann, Bernd
|
|
1998
|
|
4 |
p. 223-226
4 p.
|
artikel
|
| 29 |
Literature highlights:Infectious disease drug resistance: summaries of recent papers
|
|
|
2003
|
|
4 |
p. 219-223
5 p.
|
artikel
|
| 30 |
Literature Highlights: Recent research in infectious disease drug resistance
|
|
|
2005
|
|
4 |
p. 259-264
6 p.
|
artikel
|
| 31 |
Lysosomes and endoplasmic reticulum: Targets for improved, selective anticancer therapy
|
Linder, Stig
|
|
2005
|
|
4 |
p. 199-204
6 p.
|
artikel
|
| 32 |
Meetings Calendar
|
|
|
1999
|
|
4 |
p. 277-280
4 p.
|
artikel
|
| 33 |
MEETINGS CALENDAR
|
|
|
2000
|
|
4 |
p. 257-261
5 p.
|
artikel
|
| 34 |
Metastases and their microenvironments: linking pathogenesis and therapy
|
Sierra, Angels
|
|
2005
|
|
4 |
p. 247-257
11 p.
|
artikel
|
| 35 |
Multiple resistance mechanisms to azole antifungals in yeast clinical isolates
|
Sanglard, Dominique
|
|
1998
|
|
4 |
p. 255-265
11 p.
|
artikel
|
| 36 |
New approaches to reverse resistance to hormonal therapy in human breast cancer
|
Weinberg, Olga K.
|
|
2005
|
|
4 |
p. 219-233
15 p.
|
artikel
|
| 37 |
NF- κ B and chemoresistance: could NF- κ B be an antitumor target?
|
Bentires-Alj, Mohamed
|
|
1999
|
|
4 |
p. 274-276
3 p.
|
artikel
|
| 38 |
NF- κ B and chemoresistance: potentiation of cancer drugs via inhibition of NF- κ B
|
Cusack, James C.
|
|
1999
|
|
4 |
p. 271-273
3 p.
|
artikel
|
| 39 |
[No title]
|
Kuritzkes, Daniel R.
|
|
1998
|
|
4 |
p. 279-280
2 p.
|
artikel
|
| 40 |
Overuse of antibiotics for acute respiratory illnesses and the epidemic of penicillin-resistant Streptococcus Pneumoniae
|
Gonzales, Ralph
|
|
1998
|
|
4 |
p. 221-222
2 p.
|
artikel
|
| 41 |
Perspectives for combination therapy to overcome drug-resistant multiple myeloma
|
Catley, Laurence
|
|
2005
|
|
4 |
p. 205-218
14 p.
|
artikel
|
| 42 |
Potential and caveats of TRAIL in cancer therapy
|
Held, Jürgen
|
|
2001
|
|
4 |
p. 243-252
10 p.
|
artikel
|
| 43 |
Proteasome inhibitors as potential novel anticancer agents
|
Dou, Q.Ping
|
|
1999
|
|
4 |
p. 215-223
9 p.
|
artikel
|
| 44 |
Recent insights into platinum drug resistance in cancer
|
Johnson, Steven W.
|
|
1998
|
|
4 |
p. 243-254
12 p.
|
artikel
|
| 45 |
Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy
|
Fan, Meiyun
|
|
2001
|
|
4 |
p. 253-267
15 p.
|
artikel
|
| 46 |
Schistosome resistance to praziquantel
|
Fallon, Padraic G.
|
|
1998
|
|
4 |
p. 236-241
6 p.
|
artikel
|
| 47 |
Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors
|
Queiroz, Karla C.S.
|
|
2012
|
|
4 |
p. 211-222
12 p.
|
artikel
|
| 48 |
34th annual meeting of the american society of oncology (ASCO) Los Angeles, California, USA, 16–19 May 1998
|
de Vries, Elisabeth G.E.
|
|
1998
|
|
4 |
p. 281-283
3 p.
|
artikel
|
| 49 |
The cost of antibiotic resistance from a bacterial perspective
|
Björkman, Johanna
|
|
2000
|
|
4 |
p. 237-245
9 p.
|
artikel
|
| 50 |
The role of Fas and FasL as mediators of anticancer chemotherapy
|
Poulaki, Vassiliki
|
|
2001
|
|
4 |
p. 233-242
10 p.
|
artikel
|
| 51 |
The role of pro-drug therapy in the treatment of cancer
|
Ferguson, Michelle J.
|
|
2001
|
|
4 |
p. 225-232
8 p.
|
artikel
|
| 52 |
Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs
|
Ackland, Stephen P.
|
|
1999
|
|
4 |
p. 205-214
10 p.
|
artikel
|
| 53 |
Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic options
|
Malathum, Kumthorn
|
|
1999
|
|
4 |
p. 224-243
20 p.
|
artikel
|
Tijdschrift beschrijving